These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31427215)

  • 1. Preventive therapy compliance in pediatric tuberculosis - A single center experience.
    Santos JC; Silva JB; Rangel MA; Barbosa L; Carvalho I
    Pulmonology; 2020; 26(2):78-83. PubMed ID: 31427215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection.
    Gray EL; Goldberg HF
    Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents.
    Chang SH; Eitzman SR; Nahid P; Finelli ML
    J Infect Public Health; 2014; 7(2):145-52. PubMed ID: 24361084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.
    Bright-Thomas R; Nandwani S; Smith J; Morris JA; Ormerod LP
    Arch Dis Child; 2010 Aug; 95(8):600-2. PubMed ID: 20530147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study.
    Chang AH; Polesky A; Bhatia G
    BMC Public Health; 2013 Sep; 13():894. PubMed ID: 24073620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
    Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
    BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of adherence to isoniazid chemoprophylaxis in children in contact with adults with tuberculosis in Southern Ethiopia.
    Garie KT; Yassin MA; Cuevas LE
    PLoS One; 2011; 6(11):e26452. PubMed ID: 22069451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up results of isoniazid chemoprophylaxis during biological therapy in Colombia.
    Cataño JC; Morales M
    Rheumatol Int; 2015 Sep; 35(9):1549-53. PubMed ID: 25763992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abandonment of Treatment for Latent Tuberculosis Infection and Socioeconomic Factors in Children and Adolescents: Rio De Janeiro, Brazil.
    Mendonça AM; Kritski AL; Land MG; Sant'Anna CC
    PLoS One; 2016; 11(5):e0154843. PubMed ID: 27149514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tele-TB: Using TeleMedicine to Increase Access to Directly Observed Therapy for Latent Tuberculosis Infection.
    Donahue ML; Eberly MD; Rajnik M
    Mil Med; 2021 Jan; 186(Suppl 1):25-31. PubMed ID: 33499464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
    Gerona R; Wen A; Chin AT; Koss CA; Bacchetti P; Metcalfe J; Gandhi M
    PLoS One; 2016; 11(5):e0155887. PubMed ID: 27191185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of latent tuberculosis infection.
    Parekh MJ; Schluger NW
    Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.
    Eidlitz-Markus T; Zeharia A; Baum G; Mimouni M; Amir J
    Chest; 2003 Mar; 123(3):736-9. PubMed ID: 12628871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.
    Séraphin MN; Hsu H; Chapman HJ; de Andrade Bezerra JL; Johnston L; Yang Y; Lauzardo M
    BMC Public Health; 2019 Sep; 19(1):1214. PubMed ID: 31481046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data.
    Stockbridge EL; Miller TL; Carlson EK; Ho C
    BMC Public Health; 2018 May; 18(1):662. PubMed ID: 29843664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
    Li J; Munsiff SS; Tarantino T; Dorsinville M
    Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.